Director/PDMR Shareholding

RNS Number : 7125C
Judges Scientific PLC
29 June 2016
 

Press Release

29 June 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Director/PDMR Shareholding

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, has been advised that today David Cicurel, a Director and the Chief Executive Officer, and his wife Alejandra Cicurel, have each sold 1,100 Ordinary Shares of 5p each ("Ordinary Shares") and repurchased the same number of shares through their respective ISAs.  In addition, David Cicurel sold 7,270 Ordinary shares owned by him to his SIPP.  All sales were made at 1390p each and all purchases were made at 1390.5p each.  David Cicurel's beneficial interest in the Company remains unchanged at 916,747 Ordinary Shares representing 15.02% of the Company's current issued share capital.  In addition, he holds options over 9,275 Ordinary Shares under the Company's Share Option Plans.

 

 

-Ends-

 

For further information please contact:

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

Media enquiries:

Abchurch (Financial Public Relations)

 

Julian Bosdet

Canace Wong

Nessyah Hart

Tel: +44 (0) 20 7398 7714

www.abchurch-group.com

 

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses.  The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's awards for innovation and export.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBLGDLBXDBGLC
UK 100

Latest directors dealings